our goal is to make cancer research faster & more cost effective

by delivering research biosimilars at a faster rate to allow you to iterate your experiments faster

About Us

with you at the coalface of I-O research

biosimilars, bispecifics, ADCs, in vivo antibodies and isotype controls

View Products

looking out for the little guy

supportive of not-for-profits, academia and industry with simple, cost effective pricing to make your budget go further

Pricing

Latest news

Updated 2023 price comparison with Bio X Cell: academic customers can save up to 35% [...]

17
Feb

Updated 2023 price comparison with Bio X Cell: industry customers can save up to 50% [...]

17
Feb

We’re pleased to announce the release of our updated therapeutic antibody sequence report which now [...]

16
Feb
International Day of Women and Girls in Science
International Day of Women and Girls in Science

Today is The International Day of Women and Girls in Science and the ichorbio team [...]

11
Feb
Therapeutic Antibody Sequence Report

ichorbio has just published a list sequences of more than 660 therapeutic antibodies. As far [...]

24
Jan
Lunar New Year 2023

Wishing all our friends and colleagues throughout Asia a very happy Spring Festival and all [...]

22
Jan
Happy New Year / Biosimilar Promotion
January 1, 2023

Happy New Year to all our friends and colleagues – we hope that 2023 is [...]

New Product: Rosopatamab

ichorbio has just released a research grade (RUO) biosimilar to Rosopatamab. Rosopatamab Biosimilar – Research [...]

01
Aug

Testimonials

“having access to so many biosimilars allows us to quickly validate and compare our pipeline with biosimilars both on the market and in clinical trials”

Leading I-O biotech

“we validated two biosimilars from ichorbio and were very pleased with the results. We’ve now moved ahead with a multi-gram order”

Pharma